References
- Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45: 789–96
- Wilson WH. Clinical review of clozapine treatment in a state hospital. Hosp Community Psychiatry 1992; 43: 700–3
- Wilson WH, Clausen AM. 18-month outcome of clozapine treatment for 100 patients in a state psychiatric hospital. Psychiatr Serv 1995; 46: 386–9
- Meltzer HY, Burnett S, Bastani B, Ramirez LF. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Community Psychiatry 1990; 41: 892–7
- Tollefson GD, Beasley CM, Jr, Tran PV, Street JS, Krueger JA, Tamura RN, et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry 1997; 154: 457–65
- Miller DD, Perry PJ, Cadoret RJ, Andreasen NC. Clozapine's effect on negative symptoms in treatment-refractory schizophrenics. Compr Psychiatry 1994; 35: 8–15
- Carpenter WT, Jr, Conley RR, Buchanan RW, Breier A, Tamminga CA. Patient response and resource management: another view of clozapine treatment of schizophrenia. Am J Psychiatry 1995; 152: 827–32
- Sacks O. Awakenings. Harper Perennial, New York 1990
- Kubler-Ross E. On death and dying. Macmillan, New York 1969
- Amador XF, Flaum M, Andreasen NC, Strauss DH, Yale SA, Clark SC, et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry 1994; 51: 826–36
- Ghaemi SN, Pope HG, Jr. Lack of insight in psychotic and affective disorders: a review of empirical studies. Harvard Rev Psychiatry 1994; 2: 22–33
- Post L. Risperidone, [Letter], Hosp Community. Psychiatry 1994; 45: 1147
- Weiden P, Aquila R, Standard J. Atypical antipsychotic drugs and long-term outcome in schizophrenia. J Clin Psychiatry 1996; 57: 53–60
- Schwartzberg S, Wheelis J, Zarate CA, Jr. The danger of hopefulness: a clozapine “cure” of chronic psychosis. Harvard Rev Psychiatry 1996; 4: 146–52
- Helping patients deal with a reduction of psychotic symptoms [From an interview with Mary Susan Hansen]. Curr Appr Psychoses 1996; 5(7)8–9
- Weisburd DE. Media and mental illness. J Calif Alliance Ment Ill 1996; 7: 1–62
- Diagnostic and statistical manual of mental disorders.4th ed. American Psychiatric Association, Washington, DC 1994
- Davidson L, Strauss JS. Sense of self in recovery from severe mental illness. Br J Med Psychol 1992; 65: 131–45
- Kohut H, Wolf ES. The disorders of the self and their treatment: an outline. Int J Psychoanal 1978; 59: 413–25
- Bleuler E. Dementia praecox;, or, the group of, schizophrenias. International Universities, Press, New York 1950
- Breier A, Strauss JS. The role of social relationships in the recovery from psychotic disorders. Am J Psychiatry 1984; 141: 949–55
- Najarian SP. Family experience with positive client response to clozapine. Arch Psychiatr Nurs 1995; 9: 11–21
- Frankl VE. Man's search for meaning: an introduction to logotherapy.4th ed. Beacon, Boston 1992
- Goffman E. Asylums: essays on the social situation of mental patients and other inmates. Anchor, Garden City, New York 1961
- Semrad EV. Long term therapy of schizophrenia: psychoneuroses and schizophrenia. Lippincott, Philadelphia 1966
- Roth S. The seemingly ubiquitous depression following acute schizophrenic, episodes, a neglected area of clinical, discussion. Am J Psychiatry 1970; 127: 51–8
- Arns PG, Linney JA. Work, self, and life satisfaction for persons with severe and persistent mental disorders. Psychosoc Rehab J 1993; 17: 63–79
- Meltzer HY, Cola P, Way L, Thompson PA, Bastani B, Davies MA, et al. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia. Am J Psychiatry 1993; 150: 1630–8